Between July 27, 2026, and July 31, 2026, Essity Aktiebolag (publ) repurchased a total of 280,884 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.
The share purchase is part of the SEK 3bn buyback program announced by Essity on April 22, 2026. The buyback program will extend from May 12, 2026, until the 2027 Annual General Meeting at the latest and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).
The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity’s capital allocation.
Class B shares in Essity were repurchased as follows:
| Date | Aggregated daily volume (no. of shares): | Weighted average price per day (SEK): | Total daily transaction value (SEK): |
| July 27, 2026 | 56,219 | 279.9049 | 15,735,974 |
| July 28, 2026 | 55,310 | 280.6374 | 15,522,055 |
| July 29, 2026 | 56,415 | 278.9180 | 15,735,159 |
| July 30, 2026 | 56,414 | 279.1233 | 15,746,462 |
| July 31, 2026 | 56,526 | 277.0432 | 15,660,144 |
| Total accumulated during week 31 2026 | 280,884 | 279.1180 | 78,399,793 |
| Total accumulated during the buyback program | 3,424,699 | 267.6115 | 916,488,928 |
All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on July 31, 2026, to 4,664,822 Class B shares. The total number of shares in Essity amounted on the date of this press release to 681,945,171, of which 55,113,241 Class A shares and 626,831,930 Class B shares.
For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.